{
    "2019-12-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "S&P, 500, Transports Lead Market; These 2 Stocks Drag The IBD 50",
                "features": {
                    "keywords": [
                        "S&P 500",
                        "Transports",
                        "Lead",
                        "Market",
                        "Drag",
                        "IBD 50"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "transportation",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-12-04",
                "original_text": "Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Lilly",
                        "Upbeat",
                        "2020 Outlook",
                        "FDA",
                        "PFE",
                        "MRK",
                        "Drugs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-10",
                "original_text": "Gilead (GILD) Files NDA With FDA for RA Candidate Filgotinib",
                "features": {
                    "keywords": [
                        "Gilead",
                        "NDA",
                        "FDA",
                        "RA Candidate",
                        "Filgotinib"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-20",
                "original_text": "Troubled Traders",
                "features": {
                    "keywords": [
                        "Troubled",
                        "Traders"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}